Notice of Change in Application Due Date for RFA-CA-17-027 "Pediatric Early Phase Clinical Trials Network (UM1)"

Notice Number: NOT-CA-17-072

Key Dates
Release Date:  July 6, 2017

Related Announcements
 RFA-CA-17-027

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants about a change in application due date for RFA-CA-17-027 "Pediatric Early Phase Clinical Trials Network (UM1)" from August 16, 2017 to September 14 2017.

Other Key Dates for RFA-CA-17-027 are updated as shown below:

Open Date (Earliest Submission Date)

August 14, 2017

Letter of Intent Due Date(s)

30 days prior to the application due date

Application Due Date(s)

September 14, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.

 

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

 

AIDS Application Due Date(s)

Not Applicable

 

Scientific Merit Review

October-November 2017

Advisory Council Review

January 2018

Earliest Start Date

April 2018

Expiration Date

September 15, 2017

Inquiries

Please direct all inquiries to:

Malcolm A. Smith, MD, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6087
Email: Malcolm.Smith@nih.gov